Related Experiment Video
Updated: May 12, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide
J-P Brandel1, L Peckeu, S Haïk
1Cellule nationale de référence des maladies de Creutzfeldt-Jakob, groupe hospitalier Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France; Inserm, UMR-S-975, équipe maladie d'Alzheimer-Maladies à prions, Paris, France; CNRS, UMR 7225, Paris, France; Centre de recherche de l'institut du cerveau et de la moelle épinière (CRICM), UMRS 975, équipe Alzheimer's and Prion Diseases, université Pierre-et-Marie Curie-Paris 06, Paris, France.
Abstract:
France, involved for a long time in the epidemiological surveillance of transmissible spongiform encephalopathy (TSE), created a national network of surveillance in 1991, because of the description of the first cases of Creutzfeldt-Jakob disease (CJD) linked to a treatment by growth hormone of human origin and the observation of cases of cats infected with the agent of the bovine spongiform encephalopathy in the United Kingdom (UK). The French surveillance network is integrated into the European network of surveillance since its creation in 1993. As in other countries, sporadic CJD is the most frequent form of TSE in France with an annual mortality rate of 1.44 per million. Genetic forms are most often associated with a mutation at codon 200. Among the cases of iatrogenic CJD, 13 cases of CJD after duramater grafts were observed and 119 related to treatment with growth hormone. France is the country worst affected in Europe and the world by this latter form, before the USA and UK. Since 1996, 27 cases of variant of CJD (vCJD) has been observed, making France the second country in the world most affected after the UK. No cases of transfusion-associated vCJD have been observed.
More Related Videos
07:47Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
Published on: December 6, 2016
05:44The c-FOS Protein Immunohistological Detection: A Useful Tool As a Marker of Central Pathways Involved in Specific Physiological Responses In Vivo and Ex Vivo
Published on: April 25, 2016
Related Concept Videos
Principles of Disease Surveillance
Investigation of Disease Outbreaks
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Encephalitis l: Introduction
Arboviral Encephalitis
Huntington Disease l: Introduction